Abbott Laboratories
ABT Healthcare Medical Devices
Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 13.0%, EPS fell 47.5%, free cash flow grew 28.9% and total debt rose 142.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.
Follow ABT
Abbott Laboratories (ABT) EV/FCF
As of 16 October 2026, Abbott Laboratories (ABT) trades at a EV/FCF of 26.8×. Over the past ten years it has ranged from 20.3× (October 2022) to 47.2× (November 2020); the current reading is higher than 22% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 30.0× | (6.01%) |
| FY2024 | 32.0× | (18.57%) |
| FY2023 | 39.2× | 54.14% |
| FY2022 | 25.5× | (14.53%) |
| FY2021 | 29.8× | (17.03%) |
| FY2020 | 35.9× | (3.51%) |
| FY2019 | 37.2× | 28.16% |
| FY2018 | 29.0× | 6.94% |
| FY2017 | 27.1× | (5.14%) |
| FY2016 | 28.6× | (20.64%) |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 23.6× | (15.20%) |
| Mar 2026 | 27.9× | (7.20%) |
| Dec 2025 | 30.0× | (12.91%) |
| Sep 2025 | 34.5× | (3.96%) |
| 42 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| PHG Koninklijke Philips N.V. compare | 16.1× |
| BSX Boston Scientific Corporation compare | 21.3× |
| MDT Medtronic PLC compare | 22.9× |
| DXCM DexCom, Inc. compare | 23.5× |
| STE STERIS plc compare | 24.7× |
| GEHC GE HealthCare Technologies Inc. compare | 25.9× |
| SYK Stryker Corporation compare | 26.5× |
| ABT Abbott Laboratories | 26.8× |
| EW Edwards Lifesciences Corporation compare | 33.4× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on ABT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement